| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.087 | 0.007 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.007 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.008 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.085 | 0.009 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.37 | 0.01 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |